In the past week, ALKS stock has gone up by 0.35%, with a monthly decline of -7.32% and a quarterly plunge of -10.85%. The volatility ratio for the week is 2.66%, and the volatility levels for the last 30 days are 2.49% for Alkermes plc The simple moving average for the past 20 days is -2.95% for ALKS’s stock, with a -3.85% simple moving average for the past 200 days.
Is It Worth Investing in Alkermes plc (NASDAQ: ALKS) Right Now?
The price-to-earnings ratio for Alkermes plc (NASDAQ: ALKS) is 13.81x, which is above its average ratio. Moreover, the 36-month beta value for ALKS is 0.48. Analysts have varying opinions on the stock, with 9 analysts rating it as a “buy,” 2 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for ALKS is 161.17M and currently, short sellers hold a 6.55% of that float. On July 03, 2025, ALKS’s average trading volume was 1.78M shares.
ALKS) stock’s latest price update
The stock price of Alkermes plc (NASDAQ: ALKS) has jumped by 0.05% compared to previous close of $28.99. Despite this, the company has seen a gain of 0.35% in its stock price over the last five trading days. zacks.com reported 2025-07-02 that New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position EXEL, VRNA, ALKS, KNSA and IMCR well in this volatile sector.
Analysts’ Opinion of ALKS
Many brokerage firms have already submitted their reports for ALKS stocks, with UBS repeating the rating for ALKS by listing it as a “Buy.” The predicted price for ALKS in the upcoming period, according to UBS is $42 based on the research report published on June 17, 2025 of the current year 2025.
Needham, on the other hand, stated in their research note that they expect to see ALKS reach a price target of $45. The rating they have provided for ALKS stocks is “Buy” according to the report published on May 28th, 2025.
RBC Capital Mkts gave a rating of “Sector Perform” to ALKS, setting the target price at $40 in the report published on March 13th of the current year.
ALKS Trading at -3.30% from the 50-Day Moving Average
After a stumble in the market that brought ALKS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -20.44% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALKS starting from Nichols Christian Todd, who sale 3,333 shares at the price of $31.95 back on Jun 09 ’25. After this action, Nichols Christian Todd now owns 89,542 shares of Alkermes plc, valued at $106,489 using the latest closing price.
Nichols Christian Todd, the SVP, Chief Commercial Officer of Alkermes plc, sale 3,334 shares at $31.09 during a trade that took place back on Jun 10 ’25, which means that Nichols Christian Todd is holding 86,208 shares at $103,654 based on the most recent closing price.
Stock Fundamentals for ALKS
Current profitability levels for the company are sitting at:
- 0.26 for the present operating margin
- 0.88 for the gross margin
The net margin for Alkermes plc stands at 0.23. The total capital return value is set at 0.24. Equity return is now at value 25.71, with 16.91 for asset returns.
Based on Alkermes plc (ALKS), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at 6.97. The debt to equity ratio resting at 0.05. The interest coverage ratio of the stock is 23.56.
Currently, EBITDA for the company is 494.86 million with net debt to EBITDA at -0.73. When we switch over and look at the enterprise to sales, we see a ratio of 2.94. The receivables turnover for the company is 4.75for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.33.
Conclusion
To wrap up, the performance of Alkermes plc (ALKS) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
